Full-Time

Chief Engineer CT/AMI

Posted on 2/28/2026

Philips

Philips

Manufactures sleep therapy and respiratory devices

Compensation Overview

$191.3k - $306k/yr

+ Annual Incentive Bonus + Long-Term Incentives + Stock Purchase Plan + 401k Match

No H1B Sponsorship

Cambridge, MA, USA + 1 more

More locations: Orange, OH, USA

Hybrid

Office-based; requires 3 days on-site per week.

Category
Biology & Biotech (2)
,
Requirements
  • PhD or equivalent advanced degree in Medical Imaging, Biomedical Engineering, Computer Science, Mechanical, Electrical, or related engineering field.
  • 15+ years of experience in imaging equipment development.
  • Recognized technology leader in CT/AMI imaging with a strong record of publications, patents, and technological breakthroughs.
  • Proven experience managing R&D or technical innovation teams in a global and matrixed organization.
  • Strong business acumen and ability to translate technology advancements into competitive products.
  • Demonstrated success in building and leading multidisciplinary, geographically dispersed teams.
  • Excellent communication, collaboration, and leadership skills.
  • Demonstrated ability working with key stakeholders to shape the innovation pipeline with new concepts and ideas while shaping the business portfolio.
  • Demonstrated experience leading large global multi-disciplinary technology teams. Ability to partner with critical stakeholders, including product marketing, clinical science, Service, PMO, and other enabling functions.
  • Strong and inspiring people leader with a track record of performance and leading large development teams in multiple geographies.
  • You must be able to successfully perform the following minimum Physical, Cognitive and Environmental job requirements with or without accommodation for this position.
Responsibilities
  • Shape and formulate CT/AMI technology vision and strategy, platform, and product architecture roadmap through translating the business strategy and articulating current and future customer, business, and regulatory needs, as well as inspiring cross-organizational innovation.
  • Anticipate and analyse market, regulatory, and technology trends to guide innovation pipelines, ensure compliance, and maximize customer value.
  • Lead a chief engineer office with a group of technical experts and leaders across the organization, collaborating closely with clinical experts, engineering, product marketing, service, PMO, and executive leadership.
  • Oversee global platform and product portfolios, ensuring timely, high-quality, and cost-effective project execution in alignment with business and technology strategy and roadmap.
  • Drive strategic initiatives to improve design quality and chair the technical design reviews across the organization to ensure sound technical decision-making on technology direction and design of systems and subsystems with transparency, coverage, and efficiency.
  • Inspire, mentor, and develop technical talent globally. Optimizes and develops technological competencies and product creation processes within organizational and market dynamics, improving key processes.
  • Provide oversight and governance on technical trainings, technical competency growth, and technical career path of the R&D organization.
  • Fosters and encourages an engaged, innovative, and inspiring working environment by motivating, challenging, and coaching employees towards growth and entrepreneurship, stimulating engagement and driving innovation.
  • Coordinates with relevant parties outside the department, formulating strategies across departmental borders, establishing networks to gather input on technological developments, and identifying trends.
  • Influences and leverages deep market, content, and technology knowledge to make data-driven decisions, oversees technology and application areas, and translates business content into opportunities for the R&D organization.
  • Build international recognition as a thought leader, representing Philips in technology forums, conferences, and strategic networks with academia, clinical partners, and regulatory bodies.

Philips Respironics designs sleep and respiratory care devices, including CPAP and BiPAP machines, ventilators, and oxygen concentrators, plus related systems. These devices deliver regulated air pressure, support or assist breathing, and provide concentrated oxygen, often paired with software and data tools for monitoring. The division differentiates itself through its long history within Philips and its integrated ecosystem that connects devices with analytics and clinical support across hospital, clinic, and home settings. Its goal is to improve quality of life and clinical outcomes for people with sleep and respiratory conditions by offering reliable devices, patient support, and data-driven care.

Company Size

N/A

Company Stage

Acquired

Total Funding

$5.1B

Headquarters

Murrysville, Pennsylvania

Founded

1891

Simplify Jobs

Simplify's Take

What believers are saying

  • BioTelemetry acquisition in 2020 expands remote heart monitoring.
  • $479 million settlement in September 2023 closes US litigation.
  • New silicone foam validated safe, enabling global device sales.

What critics are saying

  • ResMed seizes US sleep market share within 6-12 months.
  • FDA consent decree blocks US sales until after 2026.
  • January 2024 US ventilation exit halves revenue permanently.

What makes Philips unique

  • Pioneered CPAP therapy as standard for sleep apnea since 1976.
  • Leads in non-invasive ventilation and home respiratory support.
  • Integrates devices with software for data-driven clinical outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

401(k) Retirement Plan

401(k) Company Match

Unlimited Paid Time Off

Health Savings Account/Flexible Spending Account

Company News

HIT Consultant
Apr 12th, 2024
Philips Respironics Reaches Final Agreement With Us Regulators On Sleep Apnea Device Recall

<img src="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp" alt="Philips Respironics Reaches Final Agreement with US Regulators on Sleep Apnea Device Recall. " class="wp-image-78777" srcset="https://hitconsultant.net/wp-content/uploads/2024/04/Philips.webp 700w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-300x161.webp 300w, https://hitconsultant.net/wp-content/uploads/2024/04/Philips-290x155.webp 290w" sizes="(max-width: 700px) 100vw, 700px">What You Should Know: – Philips Respironics, a subsidiary of Royal Philips, has finalized a consent decree with the US Department of Justice (DOJ) and Food and Drug Administration (FDA) to address issues raised during a 2021 inspection of a Philips facility in Pennsylvania.– The agreement focuses on Philips Respironics’ operations in the US, particularly regarding the recall of certain sleep and respiratory care devices.– The company’s focus will now be on completing remediation efforts, ensuring patient safety, and regaining regulatory approval to resume sales of new devices in the US.Focus on Remediation and ComplianceThe consent decree outlines a roadmap for Philips Respironics to:Prioritize Recall Remediation: Philips will continue efforts to remediate millions of sleep apnea and respiratory care devices recalled in June 2021 due to potential health risks associated with degraded sound abatement foam.Independent Oversight: Independent experts will be brought in to review recall remediation efforts and ensure Philips Respironics’ business operations comply with FDA regulations.Continued Patient Support: Philips Respironics can continue servicing existing devices in the hands of patients and healthcare providers. Additionally, they can sell accessories, consumables, and replacement parts for these devices.Sales Restrictions Remain in USThe FDA has not yet authorized Philips Respironics to resume sales of new CPAP, BiPAP, or other respiratory care devices in the US. This restriction will remain in place until Philips meets the requirements outlined in the consent decree.Global Sales Continue with RestrictionsPhilips Respironics can continue to sell new devices, accessories, consumables, and replacement parts outside the US,  subject to specific requirements.Safety of Devices with New Foam ConfirmedPhilips Respironics has conducted tests on devices using a new silicone sound abatement foam and found no safety issues. Patients can continue to use these devices following the instructions for use.Financial ImpactPhilips anticipates incurring costs associated with remediation activities and profit disgorgement related to US sales. These costs are estimated at 100 basis points in 2024.  The company’s previously announced 2023-2025 financial outlook remains unchanged,  already factoring in the consent decree. “Strengthening patient safety and quality remains Philips’ highest priority and the increased scrutiny will help us to improve even more

Goodrich Pharmacy
Jan 29th, 2024
Phillips Suspends U.S. Sales of CPAP, Ventilator Machines After Recall

Following a recall of millions of its breathing machines that began in mid-2021, Phillips Respironics announced Monday that it would halt sales of all such machines within the United States.

Parker Waichman LLP
Mar 23rd, 2023
Sleep Apnea Patients Suffer While Waiting To Receive Their Repaired Philips CPAP Machines

In June of 2021, Philips began a recall of over five million of its breathing devices due to toxic fume and substances emanating from the devices’ sound abatement foam.

Digital Journal
Jan 13th, 2023
Ultrasound Market Share | Market | Report | Analysis 2032 | Key Players: Fujifilm Holdings Corporation, Analogic Corporation, Siemens Healthcare among others

February 2019 – Koninklijke Philips launched the EPIQ Elite ultrasound system in the market.

VentureBeat
Oct 26th, 2022
Philips Norelco Brings Movember To Roblox With Shavetopia

Register now for your free virtual pass to the Low-Code/No-Code Summit this November 9. Hear from executives from Service Now, Credit Karma, Stitch Fix, Appian, and more. Learn more. Philips Norelco is creating an interactive metaverse experience called Shavetopia in Roblox, based around the Movember trend. For anyone who doesn’t know what that is, Movember is where people grow facial hair for the entire month of November. The portmanteau comes from adding the word mustache to the name of the month

INACTIVE